ALG PHARMA
LIVE

Serial Number

79196143

Owner

AMADEITE

Attorney

Jeannine A Rittenhouse

Filing Date

Jul 7, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ALG PHARMA Trademark

Serial Number: 79196143 • Registration: 5445428

ALG PHARMA is a trademark filed by AMADEITE on July 7, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AMADEITE (9 trademarks)

BRÉHAN 56580 , FR

Entity Type: 99

Trademark Details

Filing Date

July 7, 2016

Registration Date

April 17, 2018

Published for Opposition

January 30, 2018

Cancellation Date

November 1, 2024

Goods & Services

Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; sanitary preparations for medical purposes; dietetic foods adapted for medical purposes for human use, namely, cereals and cereal-based foods made with grains and flours in the nature of breads, pastas, tortillas, sweet biscuits, savoury biscuits, cakes, doughs, crispbread and breakfast cereals, vegetables and vegetable-based foods made with texturized vegetable protein, leaf proteins, soya, fungi, vegetable juices, algae, fruit juices, nuts and seeds and nut-based foods, fish, mollusks and their eggs, crustaceans and their eggs, processed, dried, salted, smoked and canned fish, meat and meat-based foods in the nature of processed meat, eggs, milk and milk-based foods and beverages in the nature of creams, yoghurts, cheeses, milk-based cream desserts and ice creams, sugars and syrups being confectionery, desserts, jams jellies, preserves, beverages in the nature of teas, coffees, cordials, soft drinks, fruit flavoured drinks, herbs, spices; food for babies; food supplements for humans; disinfectants; preparations for destroying vermin; fungicides, [ herbicides, ] parasiticides * ; all the aforesaid goods pertaining to the pharmaceutical sector * ; plant extracts for pharmaceutical use; medicinal plant extracts; diagnostic agents for medical purposes; living cells for medical use; stem cells for medical use; enzymes for medical use; bacteriological preparations for medical use; plant preparations being plan extracts for medical use; bacteriological preparations for medical use; biochemical preparations for medical purposes, namely, for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; biological preparations for medical use, namely, for the for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorders, of urinary and sexual disorders, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; biotechnological preparations for medical use, namely, for the for the prevention and treatment of cancers, of disorder of the central nervous system, of digestive disorder, of respiratory disorder, of urinary and sexual disorder, of immunity system disorder, of bone and joint disorder, of mucosal and skin disorder, of vascular and hemostasis disorder, and of infectious disease; alginates for pharmaceutical use; iodine for pharmaceutical use * ; all the aforesaid goods being algae-based and none of these goods intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases *

Seaweeds for use as fertilizers; algae for use as fertilizers; calcium-based algae nutrient supplements for use in aquariums; algae extracts for the manufacture of pharmaceutical products, namely, in the nature of dietary food supplements, pharmaceuticals and veterinary products; nutritive additive to enhance the biological activity of plants for purposes of fertilization and bioremediation of pollutants; seaweed and seaweed extracts for preventing infections in plants; chemical preparations of trace elements for preventing infections in plants; plant growth regulating preparations; cultures of microorganisms other than for medical and veterinary use; biological tissue cultures other than for medical or veterinary [ purposes ] * use * ; biological preparations for use in cell cultures other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary [ purposes ] * use * ; preparations of microorganisms other than for medical or veterinary use; chemical reagents other than for medical or veterinary use; chemical preparations for scientific use other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use * ; all the aforesaid goods being algae-based and none of these goods intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases *

Chemical analysis ; scientific analyses, namely, scientific research and scientific laboratory services ; engineering services in the fields of science and technology provided by engineers; scientific and technical research in the fields of human health, human nutrition, animal welfare, animal health, animal nutrition, horticulture and agriculture, algae-based products for food industry and human health; medical research; development of pharmaceutical preparations and medicines; research in the field of pharmaceuticals; research and development in the field of pharmaceuticals; conducting clinical trials for pharmaceutical products; research and development of new products for others in the field of pharmaceuticals; scientific research and development; research and development of vaccines and medicines; medical research laboratory services; conducting scientific feasibility studies * ; all the aforesaid services in connection with the study of algae and none of these services intended for use in connection with the treatment of allergies, asthma, rhinitis, anaphylactic reactions and other respiratory diseases *

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Dec 25, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 6, 2025 INTS
INVALIDATION PROCESSED
Dec 6, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 1, 2025 INTR
CANCELLED SECTION 71
Nov 1, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 17, 2023 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 25, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2022 NREP
CORRECTION UNDER SECTION 7 - PROCESSED
Jun 14, 2021 COC.
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 19, 2021 COC.
LIMITATION FROM THE IB EXAMINED AND ENTERED
Sep 21, 2018 LIME
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 31, 2018 FINO
LIMITATION OF GOODS RECEIVED FROM IB
Aug 17, 2018 LIMG
FINAL DISPOSITION NOTICE SENT TO IB
Aug 4, 2018 FICS
FINAL DISPOSITION PROCESSED
Aug 4, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 17, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 17, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jan 26, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 10, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 10, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 21, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 21, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 21, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 21, 2017 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 6, 2017 GNFN
FINAL REFUSAL E-MAILED
Jul 6, 2017 GNFR
FINAL REFUSAL WRITTEN
Jul 6, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 7, 2017 TROA
REFUSAL PROCESSED BY IB
Dec 24, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 7, 2016 RFCS
REFUSAL PROCESSED BY MPU
Dec 7, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 24, 2016 RFCR
NON-FINAL ACTION WRITTEN
Nov 23, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 22, 2016 MAFR
ASSIGNED TO EXAMINER
Nov 18, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 17, 2016 REPR